Print Page   |   Contact Us   |   Sign In   |   Join
21st Century Therapeutics, Inc.
Profile Pages More
Photo Not Available
Last updated: 9 hours ago
21st Century Therapeutics, Inc.
Bioscience Company
Organization Information
21st Century Therapeutics, Inc.
440 Burroughs St
Detroit
Michigan
48202  United States
 [ Map ]
Visit Website »
  Wayne
  We are in the business of discovering and development of new drugs in cancer and immune-mediated diseases.

Chemoprotector:
UTL-5g is a small-molecule tumor necrosis factor alpha (TNF-a) inhibitor under development as a chemoprotetive agent. This project has received an SBIR Phase I grant and the proposed preclinical studies have been completed satisfactorily.

Radioprotector:
The Company’s second project is to develop UTL-5g for its potential to reduce lung injury induced by radiation.

Natural Products:
In addition to the leading projects, 21st CTI has several other promising projects. Furthermore, we have over 20,000 extracts from natural products (marine and plants) in stock for screening and we have identified over 100 preliminary leads for secondary screening as potential therapeutic agents.
  Pharma & Therapeutics - Rx & Consumer Health
  Pharma & Therapeutics - Rx & Consumer Health
  Immunology/Inflammation, Oncology
  Preclinical
  UTL-5g is a small-molecule tumor necrosis factor alpha (TNF-a) inhibitor under development as a chemoprotetive agent.
  541711 - R&D; biotechnology
  2002
Contact Information
Visit My Website »
Creating Value
by delivering business-critical resources & bottom line savings
Building Networks
by connecting Michigan's bio-industry one member at a time
Growing Talent
by creating opportunities that develop people & build organizations
Membership Software Powered by YourMembership  ::  Legal